Axonal loss in multiple sclerosis lesions: magnetic resonance imaging insights into substrates of disability. - Wikidata - wikimedia - TriplyDB

Axonal loss in multiple sclerosis lesions: magnetic resonance imaging insights into substrates of disability.

Axonal loss in multiple sclerosis lesions: magnetic resonance imaging insights into substrates of disability.

http://www.wikidata.org/entity/Q33879542

about

Improving the characterization of radiologically isolated syndrome suggestive of multiple sclerosis Imaging correlates of leukocyte accumulation and CXCR4/CXCL12 in multiple sclerosis Characterizing iron deposition in multiple sclerosis lesions using susceptibility weighted imaging Magnetic resonance spectroscopy of normal appearing white matter in early relapsing-remitting multiple sclerosis: correlations between disability and spectroscopy Remyelination Therapy in Multiple Sclerosis Advancing Cardiovascular, Neurovascular, and Renal Magnetic Resonance Imaging in Small Rodents Using Cryogenic Radiofrequency Coil Technology The impact of utilizing different optical coherence tomography devices for clinical purposes and in multiple sclerosis trials Astrocyte-derived tissue Transglutaminase affects fibronectin deposition, but not aggregation, during cuprizone-induced demyelination A review of structural magnetic resonance neuroimaging.Optic nerve magnetisation transfer ratio after acute optic neuritis predicts axonal and visual outcomes.Clinical, MRI, and CSF markers of disability progression in multiple sclerosis.Advanced MRI and staging of multiple sclerosis lesions A review of the use of magnetic resonance imaging in Parkinson's disease.Removal of cerebrospinal fluid partial volume effects in quantitative magnetization transfer imaging using a three-pool model with nonexchanging water component.Imaging of multiple sclerosis: role in neurotherapeutics.Measuring longitudinal myelin water fraction in new multiple sclerosis lesions.Heterogeneity of Multiple Sclerosis Lesions in Multislice Myelin Water Imaging.Imaging as an Outcome Measure in Multiple Sclerosis.Assessment of multiple sclerosis lesions with spherical harmonics: comparison of MR imaging and pathologic findings.MRI in multiple sclerosis: current status and future prospects Increased diffusivity in acute multiple sclerosis lesions predicts risk of black hole Outcome measures in relapsing-remitting multiple sclerosis: capturing disability and disease progression in clinical trials.Age independently affects myelin integrity as detected by magnetization transfer magnetic resonance imaging in multiple sclerosis.Brain tissue sodium concentration in multiple sclerosis: a sodium imaging study at 3 tesla.Targeting Cognitive Impairment in Multiple Sclerosis-The Road toward an Imaging-based Biomarker Ocular pathology in multiple sclerosis: retinal atrophy and inflammation irrespective of disease duration.Hypothalamic Dysfunction and Multiple Sclerosis: Implications for Fatigue and Weight Dysregulation ADvanced IMage Algebra (ADIMA): a novel method for depicting multiple sclerosis lesion heterogeneity, as demonstrated by quantitative MRI.Deficient MWF mapping in multiple sclerosis using 3D whole-brain multi-component relaxation MRI.Structural and functional hallmarks of amyotrophic lateral sclerosis progression in motor- and memory-related brain regions.Neurological rehabilitation: from mechanisms to management.Histological-MRI correlation in the primary motor cortex of patients with amyotrophic lateral sclerosis Cerebral atrophy as outcome measure in short-term phase 2 clinical trials in multiple sclerosis Subcortical biophysical abnormalities in patients with mood disorders.Contrasting roles for CD4 vs. CD8 T-cells in a murine model of virally induced "T1 black hole" formation.Axonal damage in the making: neurofilament phosphorylation, proton mobility and magnetisation transfer in multiple sclerosis normal appearing white matter.Magnetization transfer and adiabatic T1ρ MRI reveal abnormalities in normal-appearing white matter of subjects with multiple sclerosis.Evolving expectations around early management of multiple sclerosis.Automated determination of axonal orientation in the deep white matter of the human brain.Damage to the optic chiasm in myelin oligodendrocyte glycoprotein-experimental autoimmune encephalomyelitis mice

P2860

Q21560827-093101A5-2404-402C-810A-9EA18813EF85 Q24641998-E0B9C5DA-B1C7-4554-A72B-177E80E701B5 Q24645501-CF7A67CE-0ECA-461F-AECE-29CFA5E0198D Q24800569-438A49C9-F8E5-4667-B2A0-A7F80FECC994 Q26772359-6D461C77-61A4-4083-A092-E303C1DBA442 Q26776191-876A9589-E4B5-4868-A8C9-98213CAB3B87 Q28741521-C15778AA-2F26-44F3-99D9-454CD5B89530 Q29248440-355A71CA-9BFB-440B-8B48-2B63063B14AF Q30495444-78722919-8C0F-4BDB-A2A4-23AE9B2AF90C Q30583486-2B62E168-C955-4495-852D-1199BAF9B054 Q30712257-14FF2818-AB40-47A3-B421-63AEEB72C500 Q30825494-A65AC547-5A6A-4C4F-884C-690745D46CBD Q30835548-E670B5B5-F33C-4B81-8D16-B4035F37E5F4 Q30869479-3D07BE3F-1842-4757-8B26-C9094EBE173C Q30989935-F2861055-187D-4C37-AD8E-2E51FD3D6E65 Q31027246-F2D72779-94D4-46FF-B2C9-036066B61139 Q31060441-6B327287-B7AF-40EE-A0D1-6CE8A28B502D Q31134617-006750AD-C0D9-49D4-B658-743D000C285C Q33214087-DB4EBCC4-40DE-4FC7-83D9-ED1B9A81465D Q33345057-FCAA5E0C-C19B-4FD5-B08D-E2850338BCB8 Q33586037-7B857259-23E9-493B-A5FD-26B48F3FAC36 Q33634866-7A0043C1-661C-41CB-A15D-7D2601CD82C6 Q33741396-970E1D3D-4FDE-48C6-8B15-D050DB1401A6 Q33742402-D08EBE40-98AA-4D59-829A-81F4B7D8AAD8 Q33855765-8D8A45BE-C905-4FDE-8079-6AD35EC8CF9F Q33882723-E1ED226C-4B91-4B43-8BA7-8E22DFC5E1C1 Q33887434-FBC5D493-FA4A-44D4-B23D-D0E5FA0CC50F Q33921391-49946553-B1DF-4CDC-986C-5A9D21409BC6 Q34020232-3E6064E7-38ED-4CB2-B880-53311F472BAE Q34079265-F7653B55-2E4A-4652-A5D0-1080B345BB13 Q34083591-5D129FB7-652C-4B86-943C-A2F0CBEA36A1 Q34090704-FBB45444-0E55-4C3E-866E-217D6897654A Q34123689-C69A104B-A83C-4D16-A2BD-013921AF1890 Q34158919-4F467C8E-C7E7-4A0C-B445-9A17AAD71F83 Q34163547-2BEE44CA-16CC-47D9-B68E-43ADAC6D1EEB Q34220288-70DF171F-36FE-472E-BDE9-58A84471C5A8 Q34391804-01D31E20-416E-46B6-90D8-0F6C3C801130 Q34409412-612D3A08-B127-4F4B-8101-AF0A8E8EB938 Q34431731-04CA60C7-5F10-4C1E-8773-07E96D56AD0E Q34482163-A3C3CE9E-B2C0-490F-8E20-7A932495295D

P2860

Axonal loss in multiple sclerosis lesions: magnetic resonance imaging insights into substrates of disability.

http://www.wikidata.org/entity/Q33879542

description

1999 nî lūn-bûn

@nan

1999 թուականի Նոյեմբերին հրատարակուած գիտական յօդուած

@hyw

1999 թվականի նոյեմբերին հրատարակված գիտական հոդված

@hy

1999年の論文

@ja

1999年論文

@yue

1999年論文

@zh-hant

1999年論文

@zh-hk

1999年論文

@zh-mo

1999年論文

@zh-tw

1999年论文

@wuu

name

Axonal loss in multiple sclero ...... into substrates of disability.

@ast

Axonal loss in multiple sclero ...... into substrates of disability.

@en

type

label

Axonal loss in multiple sclero ...... into substrates of disability.

@ast

Axonal loss in multiple sclero ...... into substrates of disability.

@en

prefLabel

Axonal loss in multiple sclero ...... into substrates of disability.

@ast

Axonal loss in multiple sclero ...... into substrates of disability.

@en

P1433

Q33879542-FF4B1B68-32AA-4748-A738-0D235546EE7A

P1476

Q33879542-DD2E59A9-50E0-4CDF-B979-8756B434F8BC

P2093

Q33879542-09044B75-B5AA-4FCE-93F7-69171DFBDA10

Q33879542-10E26228-0646-484B-A2FF-1B5B13F55411

Q33879542-1E73D5E5-8842-4737-A7D8-D21C20372159

Q33879542-53C3780D-05DC-4E74-869F-151A9624F47A

Q33879542-59F01073-477B-4D03-AB48-F44AB2EB076C

Q33879542-BE512D26-3AD7-4B6A-915D-CDB1C8468FA3

Q33879542-C57BCB9B-AF35-46A8-9D60-B40F3B4D76EC

Q33879542-DA2DEAFC-5C01-434F-A59E-6F91F18F0E59

Q33879542-DB7F1BCF-4B93-4F51-8FF2-EEF5245C58A2

Q33879542-F07DCDDE-10CB-47CE-9DFB-EB27AC634D25

P304

Q33879542-773D09C3-C1C5-4637-8403-2FF004924B5B

P31

Q33879542-53330571-7C1A-4863-BBD7-54F97061D230

P356

Q33879542-907B5650-8F6D-4BB3-8BAC-72621F242086

P433

Q33879542-EC28D86B-11C5-4CCB-878A-AB5151AE91F8

P478

Q33879542-CDA2E356-74AA-49E5-B9A3-394330A12A9E

P577

Q33879542-9D826989-4175-4C2B-AFD3-FA8640507B9C

P698

Q33879542-6C07C4D5-ABDF-469C-9248-09756733E940

P921

Q33879542-89FBCB5F-3CA7-404C-823F-62843DD8B581

P356

1531-8249(199911)46:5%3C747::AID-ANA10%3E3.3.CO;2-W

P1433

Annals of Neurology

P1476

Axonal loss in multiple sclero ...... into substrates of disability.

@en

P2093

A J Thompson

http://www.w3.org/2001/XMLSchema#string

C H Polman

http://www.w3.org/2001/XMLSchema#string

C J De Groot

http://www.w3.org/2001/XMLSchema#string

F Barkhof

http://www.w3.org/2001/XMLSchema#string

G J Lycklama à Nijeholt

http://www.w3.org/2001/XMLSchema#string

J A Castelijns

http://www.w3.org/2001/XMLSchema#string

J H van Waesberghe

http://www.w3.org/2001/XMLSchema#string

M A van Walderveen

http://www.w3.org/2001/XMLSchema#string

P van der Valk

http://www.w3.org/2001/XMLSchema#string

R Ravid

http://www.w3.org/2001/XMLSchema#string

P304

747-754

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1002/1531-8249(199911)46:5<747::AID-ANA10>3.3.CO;2-W

http://www.w3.org/2001/XMLSchema#string

P433

5

http://www.w3.org/2001/XMLSchema#string

P478

46

http://www.w3.org/2001/XMLSchema#string

P577

1999-11-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

10553992

http://www.w3.org/2001/XMLSchema#string

P921

multiple sclerosis